share_log

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Collins James J.

SEC ·  Jul 13 04:18
Summary by Futu AI
James J. Collins, associated with Senti Biosciences, Inc. (SNTI.US), was involved in a transaction with the company's stock on July 10, 2024. The specific details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting ownership stake, have not been disclosed. This information is crucial for investors to understand the implications of insider actions on their investment decisions.
James J. Collins, associated with Senti Biosciences, Inc. (SNTI.US), was involved in a transaction with the company's stock on July 10, 2024. The specific details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting ownership stake, have not been disclosed. This information is crucial for investors to understand the implications of insider actions on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.